Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Company Profile for QIAGEN

Posted on: 02 Mar 18

QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare), Applied Testing (primarily forensics), Pharma (pharma and biotech companies) and Academia (life sciences research). As of December 31, 2017, QIAGEN employed approximately 4,700 people in over 35 locations worldwide.

Company:   QIAGEN
Headquarters Address: Qiagen Str. 1
Hilden 40724
Main Telephone: +4921032911676

Ticker/ISIN: QIA(FWB)/NL0000240000
Type of Organization: Public
Industry: Biotechnology
Key Executives: CEO: Peer Schatz
CFO: Roland Sackers
Public Relations
Contact: Thomas Theuringer
Phone: +4921032911826

Investor Relations
Contact: John Gilardi
Phone: +4921032911711

View source version on

Business Wire

Last updated on: 02/03/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.